Mark Coleman - Director at Axsome Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AXSM on Nasdaq
All Insider Reports
All Insider Reports

Mark Coleman - trading volume in the past year for Axsome Therapeutics, Inc.

Holdings reported by Mark Coleman for Axsome Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 404K $47.2M $116.99 Sep 8, 2025 Indirect
Common Stock 48.2K $6.14M $127.40 Sep 8, 2025 Direct
Stock Option (Right to Buy) 3.17K Jun 6, 2025 Direct Common Stock
Restricted Stock Units 1.43K Jun 6, 2025 Direct Common Stock

Transactions reported by Mark Coleman for Axsome Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.